Experimental Cancer Drug May Slow Inflammation Linked to Hea

/PRNewswire/ -- An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer's disease may slow the progression of...

Related Keywords

New York , United States , Claudia Calcagno , Simon Koplev , Adam Ghotbi , Chiara Giannarelli , Christopher Hill , Pauline Mury , Swathy Sajja , Zahi Fayad , Nayaab Kahn , Peik Sean Chong , Roza Shamailova , Letizia Amadori , Avi Maayan , Yannick Cyr , Nicolas Fernandez , Raphael Soler , Peter Faries , Kathryn Moore , Ravneet Kaur , Sonum Naidu , Natalia Eberhardt , Minji Jeon , Ken Sakurai , Shira Polan , Adeeb Rahman , Nature Cardiovascular Research , Library Of Integrated Network , National Institutes Of Health , Langone Health , Icahn School Of Medicine At Mount Sinai , Grossman School Of Medicine , Existing Compound Yields Potential New Therapy , National Institutes , Integrated Network Based Cellular Signatures , Icahn School , Mount Sinai , Dawn Fernandez , Avi Ma Ayan , Nyu Langone Health ,